| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/04/2011 | CN102038698A New application of morroniside |
| 05/04/2011 | CN102038660A Gastrodine solid dispersible tablet preparation and preparation method thereof |
| 05/04/2011 | CN102038655A Pain-relieving chewing tablet and preparation method of the same |
| 05/04/2011 | CN101744952B Medicine for preventing and treating unknown hyperpyrexia of pigs and application |
| 05/04/2011 | CN101653502B Application of traditional Chinese medicine huanglian jiedu tang in preparing medicament for preventing and treating rheumatoid arthritis |
| 05/04/2011 | CN101543498B Application of bitter theophylline in preparing anti-inflammation and analgesic drugs |
| 05/04/2011 | CN101513477B Analgesic medicine for external application and method for preparing same |
| 05/04/2011 | CN101502602B Viper wind-dispelling plaster |
| 05/04/2011 | CN101496859B External Chinese medicine paste for rheumatism and ostalgia |
| 05/04/2011 | CN101491533B Use of baicalin in preparing medicine |
| 05/04/2011 | CN101485757B Chinese medicinal composition for treating children's exogenous fever and preparation method thereof |
| 05/04/2011 | CN101439110B Chinese medicine for curing rheumatism |
| 05/04/2011 | CN101433648B Rheumatism plastic and preparation method thereof |
| 05/04/2011 | CN101422456B Preparation method and quality detection method for medicine composition drop-pills |
| 05/04/2011 | CN101406633B Pellet for recuperation of neck and waist |
| 05/04/2011 | CN101357168B Medicinal wine for treating rheumatic arthritis |
| 05/04/2011 | CN101322796B Pain-easing plaster for protrusion of lumbar vertebral disc |
| 05/04/2011 | CN101284834B Bi-inulicin 1, preparation method and applications thereof |
| 05/04/2011 | CN101278991B Method for testing effective ingredients of Gegen Qinlian medicine |
| 05/04/2011 | CN101278986B Process for preparing compound folium isatidis injection with membrane filter technique |
| 05/04/2011 | CN101244137B Medicament for treating pulmonitis, and high fever, lower fever, and preparation method |
| 05/04/2011 | CN101215544B Inflammation-inhibiting compounds |
| 05/04/2011 | CN101195002B Chinese medicine emplastrum for releasing ache and health care |
| 05/04/2011 | CN101125146B Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor |
| 05/04/2011 | CN101120933B Transdermal paster containing bulleyaconitine A and its preparation method |
| 05/04/2011 | CN101019627B Micro jet and instantaneous high pressure process of preparing whole lily powder |
| 05/04/2011 | CN101014580B Morpholine compound |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | US7935715 Compounds which modulate the CB2 receptor |
| 05/03/2011 | CA2556757C Oxydecahydronaphthalene modulators of hm74 |
| 05/03/2011 | CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids |
| 05/03/2011 | CA2438085C Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050030A1 Alpha adrenergic receptor modulators |
| 04/28/2011 | WO2011049979A2 Injectable formulations for intra- articular or peri-articular administration |
| 04/28/2011 | WO2011049810A2 Compositions and methods for treating inflammation and fibrosis |
| 04/28/2011 | WO2011049758A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | WO2011049659A2 Novel use and method of rapamycin to treat toxic shock |
| 04/28/2011 | WO2011049058A1 Water-based paste containing diclofenac sodium |
| 04/28/2011 | WO2011049053A1 Intestinal mucosa-inherent myeloid cells inhibiting t cell activation and utilization of same |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048479A2 Compositions that include anthocyanidins and methods of use |
| 04/28/2011 | WO2011048409A1 Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2011 | WO2011048004A1 Inhibitors of the microsomal prostaglandin e2 synthase-1 |
| 04/28/2011 | WO2011047926A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2010086454A9 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
| 04/28/2011 | WO2010038086A8 P38 map kinase inhibitors |
| 04/28/2011 | US20110098797 Drug eluting composite |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098352 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 04/28/2011 | US20110098351 Lactone compounds which can be used as antioxidant agents in pharmaceutical, cosmetic or food compositions and their method of preparation |
| 04/28/2011 | US20110098330 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 04/28/2011 | US20110098328 Heterocyclic derivatives as modulators of ion channels |
| 04/28/2011 | US20110098325 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098288 Sulfonamides as zap-70 inhibitors |
| 04/28/2011 | US20110098284 Methods and compositions for treating pain |
| 04/28/2011 | US20110098282 New compounds |
| 04/28/2011 | US20110098280 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 04/28/2011 | US20110098276 Oxycarbamoyl compounds and the use thereof |
| 04/28/2011 | US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands |
| 04/28/2011 | US20110098259 Pregnane steroids and their use in the treatment of cns disorders |
| 04/28/2011 | US20110098257 Derivatives of 4- or 5-aminosalicylic acid |
| 04/28/2011 | US20110098255 Combination of a parp inhibitor and an akt kinase activating compound |
| 04/28/2011 | US20110098254 Compositions comprising phospholipids |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110098252 Treatment of Spinal Mechanical Pain |
| 04/28/2011 | US20110098251 Bisphosphonate compounds |
| 04/28/2011 | US20110098237 Methods for inhibiting drug degradation |
| 04/28/2011 | US20110098236 Diamide inhibitors of cytochrome p450 |
| 04/28/2011 | US20110097394 Type a gelatin capsule containing pufa in free acid form |
| 04/28/2011 | US20110097384 Transdermal drug delivery device including an occlusive backing |
| 04/28/2011 | US20110097356 Anti-inflammatory and antioxidant cosmetic composition containing green tea polysaccharide and tricholoma matsutake extract |
| 04/28/2011 | US20110097350 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 04/28/2011 | US20110097331 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 04/28/2011 | US20110097327 Product and method for treatment of conditions associated with receptor-desensitization |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097302 Il-1ra-polymer conjugates |
| 04/28/2011 | DE102009043260A1 Pyridinyl-imidazolonderivate Pyridinyl-imidazolone derivatives |
| 04/28/2011 | CA2778423A1 Alpha adrenergic receptor modulators |
| 04/28/2011 | CA2778340A1 Extracts, fractions and compositions comprising acetogenins and their applications |
| 04/28/2011 | CA2778009A1 Aqueous patches containing diclofenac sodium |
| 04/28/2011 | CA2777881A1 Pyrazolopyrimidine derivatives |
| 04/28/2011 | CA2775924A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | CA2773356A1 Compositions and methods for treating inflammation and fibrosis |
| 04/27/2011 | EP2314695A2 Ligand for receptor activator of NF-kappa B, ligand is member of TNF superfamily |
| 04/27/2011 | EP2314694A2 BAFF receptor (BCMA), an immunoregulatory agent |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |